Analyzing Value

Here’s What High Readmissions Costs Hospitals

An abstract recently submitted and presented at the CHEST 2021 annual meeting found that hospitals that perform bronchoscopies can reduce readmission rates by more than half, and potentially lower costs, by adopting single-use flexible bronchoscopes.

At the end of a decade of federal oversight of hospital readmissions, Medicare is levying penalties on  nearly half the nation’s hospitals in the form of reduced payments due to excessive revisits.

The average penalty is a .64 percent reduction per Medicare patient stay from October 2021 through September 2022, according to a recent analysis in Kaiser Health News. Those fines can add up significantly — they averaged $217,000 per hospital in 2018, according to a congressional commission.

The maximum penalty, 3 percent, was imposed on 39 hospitals, while 547 hospitals saw so few readmissions that they received no penalty. Payments were reduced to 2,499 hospitals, 47 percent of all U.S. facilities.

Many hospitals are exempt because they specialize in children, psychiatric patients, or veterans. Rehabilitation and long-term care hospitals also are excluded.

Reducing readmission rates is a national priority for payers, providers and policymakers seeking to improve healthcare while reducing costs. The Hospital Readmissions Reduction Program was created in 2010 as part of the Affordable Care Act.

An abstract recently submitted and presented at the CHEST 2021 annual meeting found that hospitals that perform bronchoscopies can reduce readmission rates by more than half, and potentially lower costs, by adopting single-use flexible bronchoscopes.

That study — by Dr. Hudson Garrett, an infection prevention specialist and an Ambu consultant — looked at the health outcomes of 14,228 patients who underwent a bronchoscopy and found that single-use bronchoscopes reduced the readmissions rate 53 percent, from 7.7 percent to 3.6 percent, compared with reusables.

His study followed a safety communication update from the U.S. Food and Drug Administration on reprocessing flexible bronchoscopes. The agency recommends that healthcare providers consider single-use bronchoscopes when there is increased risk of infection and when treating COVID-19 patients.

More Pulmonology Articles
New Insights Into a Rare Lung Disease
Performing Procedures
Bronchoscopy is one of the tools used to diagnose a rare lung disease known as lymphangioleiomyomatosis, or LAM, that researchers are making inroads in understanding.
Q&A: The Changing Landscape for Respiratory Care
Respiratory Care Week
Respiratory care is evolving as respiratory therapists take on additional bedside roles, along with more responsibility for prevention by helping people manage their own chronic pulmonary diseases. Sam Giordano, the interim executive director of the American Association for Respiratory Care, shares the organization’s post-pandemic goals.
More From Single-Use Endoscopy
A New Study Finds That Kidney Stone Incidence Rates Are Higher Than We Thought

Public Health

These findings are significant because, until now, population-level data assessing the incidence of kidney stones has been limited in the U.S. A persistent increase in kidney stone incidence may create a significant need for more healthcare resources.

How One Department Drastically Decreased Errors in Instrument Processing

Prevention Challenges

By standardizing processes and implementing an educational orientation program, UofL Heath reduced errors in sterile processing by 80 percent.

What a High-Level Disinfection Evaluation Revealed at One Urology Practice

Preventing Infection

Infection preventionists investigated high-level disinfection processes after being notified of expired test strips being used and identified various breaches during reprocessing.